Related Experiment Video
Updated: Jun 28, 2026

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
Secondary stroke prevention: from guidelines to clinical practice
1University of New Mexico School of Medicine and Albuquerque VA Hospital, Albuquerque, NM, USA. graham@unm.edu
Insights
Secondary stroke prevention is crucial due to high mortality and morbidity. New guidelines emphasize individualized, evidence-based approaches for managing risk factors and using antiplatelet treatments to reduce recurrent ischemic events.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Stroke is a major cause of death and disability in the US, often stemming from atherothrombosis.
- Atherosclerosis increases the risk of recurrent ischemic events in cerebral, coronary, and peripheral vascular beds.
- Secondary prevention is a critical goal for stroke patients due to their heightened risk of further ischemic events.
Purpose of the Study:
- To review secondary stroke prevention strategies in light of recent guidelines.
- To discuss clinical implementation patterns for primary care physicians.
- To highlight emerging evidence, particularly concerning antiplatelet therapy.
Main Methods:
- Review of current evidence-based guidelines from the American Heart Association/American Stroke Association.
- Analysis of clinical implementation patterns for primary care.
- Focus on pharmacological interventions, including antiplatelet agents.
Main Results:
- New guidelines advocate for an individualized, patient-oriented approach to secondary stroke prevention.
- Recommendations cover lifestyle modifications and pharmacological management of hypertension, dyslipidemia, and diabetes.
- Emerging clinical evidence, especially for antiplatelet treatments, is discussed.
Conclusions:
- Effective secondary stroke prevention requires adherence to evidence-based guidelines.
- An individualized approach tailored to patient risk factors is essential.
- Antiplatelet therapy plays a key role in reducing recurrent ischemic events.
Abstract:
Stroke remains a leading cause of mortality and is associated with substantial morbidity in the United States. The majority of strokes are of ischemic origin, with an atherothrombotic trigger, and the clinical manifestation of atherothrombosis depends on the affected vascular site. The systemic nature of atherosclerosis means that stroke patients are at increased risk of ischemic events in several vascular beds, including cerebral, coronary and peripheral sites. Because stroke patients are at heightened risk of more ischemic events, secondary prevention is an important therapeutic goal. Recently, the American Heart Association and its division, the American Stroke Association, released new evidence-based guidelines for secondary stroke prevention in patients with ischemic stroke or transient ischemic attack. The new guidelines emphasize an individualized, patient-oriented approach to treatment based on clinical evidence. Evidence-based recommendations are set forth for the management of risk factors, including hypertension, dyslipidemia and diabetes, through lifestyle modifications and pharmacological interventions. The purpose of this paper is to review the topic of stroke prevention in light of current guidelines and clinical implementation patterns for primary care physicians, and to discuss new and emerging clinical evidence, with a focus on antiplatelet treatment.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
